Study on Mechanism of Shenqi Dihuang Decoction in Treating Diabetic Nephropathy Based on Network Pharmacology
College of Life Sciences, Zhejiang Normal University, Jinhua 321004, China
| Abstract: | Objective: To explore the mechanism of Shenqi Dihuang Decoction in treating diabetic nephropathy based on network pharmacology. Methods: The component targets of Shenqi Dihuang Decoction and diabetic nephropathy (DKD) targets were searched and screened by network database. Using Cytoscape3.7.2 software to construct a network of traditional Chinese medicine components-targets; The protein-protein interaction network (PPI) of Shenqi Dihuang Decoction for CRF treatment was constructed using STRING database, and the core targets were found out through topological analysis. Finally, biological pathway and enrichment analysis were carried out on drug-disease intersection targets. Results: A total of 106 active ingredients of Shenqi Dihuang Decoction were collected. 1532 corresponding targets; DKD disease targets 533; There are 48 common targets for drug components and diseases. Topological analysis was performed with a Degree value 2 times (14.3) higher than the average, and 4 key core targets were finally obtained. Biological process and enrichment analysis show that the prescription mainly involves 13 biological processes, 4 KEGG pathways and 3 typical pathways in treating DKD, mainly involving cell response to hormone stimulation, followed by biological processes such as neuroactive ligand-receptor interaction KEGG pathway, blood circulation, cell response to nitrogen compounds, chemical synaptic transmission, etc. Conclusion: Shenqi Dihuang Decoction mainly acts on PTGS2, NR3C1, NOS3, ESR1 and other targets. Its targets are many and its mechanism is complex. It may play a role mainly through the biological process of regulating the response degree of cells to hormone stimulation. |
| Keywords: | Network Pharmacology; Shen Qi Di Huang Tang; Diabetic Nephropathy; Mechanism Research; Targets |
| DOI: | 10.57237/j.life.2023.02.001 |
View:
Downloads:
Received: 27 April 2023
Accepted: 16 May 2023
Published Online: 23 May 2023
References
| [1] | 李芸. 参芪地黄汤对早期糖尿病肾病 (DN) 气阴两虚证病情延缓作用及炎症因子、尿β2-微球蛋白影响 [J]. 光明中医, 2019, 34 (12): 1820-1822. |
| [2] | 符杨浠, 邱晓堂, 杨文奎. 参芪地黄汤加减治疗气阴两虚血瘀证糖尿病肾病Ⅳ期临床研究 [J]. 中华中医药学刊, 2019, 37 (12): 3026-3029. |
| [3] | 李玫, 胡晓晖. 参芪地黄汤加减治疗糖尿病肾病的疗效观察 [J]. 陕西中医药大学学报, 2018, 41 (04): 81-82+100. |
| [4] | 范一超, 陆新, 曹毓, 施爱华. 应用参芪地黄汤治疗糖尿病肾病的可行性研究 [J]. 糖尿病新世界, 2017, 20 (21): 186-187. |
| [5] | 蔡朕, 汪蕾, 段昱方, 李楠, 赵文景, 张胜容. 参芪地黄汤对气阴两虚型特发性膜性肾病的疗效观察 [J]. 中国医刊, 2016, 51 (01): 82-85. |
| [6] | 王军涛. 参芪地黄汤联合四物汤治疗IgA肾病的临床观察 [J]. 临床医药文献电子杂志, 2016, 3 (04): 598-599. |
| [7] | 汪永国. 参芪地黄汤对难治性肾病综合征患者肾功能的影响 [J]. 西部中医药, 2016, 29 (05): 76-78. |
| [8] | 杨松涛. 参芪地黄汤治疗慢性肾小球肾炎气阴两虚证的疗效观察 [J]. 临床合理用药杂志, 2016, 9 (20): 53-54. |
| [9] | 马锐, 吴胜本. 中药黄酮类化合物药理作用及作用机制研究进展 [J]. 中国药物警戒, 2013, 10 (05): 286-290. |
| [10] | 张再超, 叶希韵, 徐敏华, 王耀发. 葛根黄酮降血糖防治糖尿病并发症的实验研究 [J]. 华东师范大学学报(自然科学版), 2010 (02): 77-81+126. |
| [11] | 冷锦红, 邱狮, 董佳妮, 张兰, 李文金, 于世家, 侯平. 穿山龙提取物薯蓣皂苷对糖尿病模型大鼠血清HA和5-HT的影响 [J]. 江苏中医药, 2015, 47 (08): 76-78. |
| [12] | 王晓华, 周燕, 王沛, 苏筠霞, 魏玉辉. 绵萆薢水提物及其主要成分薯蓣皂苷对肾小管上皮细胞膜乳腺癌耐药蛋白Bcrp的调控 [J]. 兰州大学学报(医学版), 2017, 43 (06): 35-40. |
| [13] | 李婷婷. 同型半胱氨酸与糖尿病肾病的甲钴胺、叶酸治疗的临床影响分析 [J]. 智慧健康, 2017, 3 (15): 34-36. |
| [14] | 袁晓红, 李鹏, 李雯, 安鹏. 清热解毒化瘀汤联合前列腺素E对脓毒症致急性肾损伤患者机体氧化应激及血清相关细胞因子水平的影响 [J]. 现代中西医结合杂志, 2019, 28 (36): 4042-4046. |
| [15] | Forstermann U, Sessa WC. Nitric oxide synthases: regulation and function [J]. Eur Heart J, 2012, 33: 829-837. |
| [16] | 裴丽珊, 沈霞, 颜永刚, 张岗, 彭亮, 王艳霞, 平凡. 基于血管内皮生长因子信号通路 / 肿瘤坏死因子信号通路的桃核承气汤防治脑卒中双向调节分子网络机制 [J]. 药学学报, 2020, 55 (05): 898-906. |
| [17] | 闫宇翔, 董晶, 刘佑琴, 蒙世佼, 郑德艳, 王嵬. NR3C1基因多态性与心血管疾病危险因素相关性 [J]. 中国公共卫生, 2015, 31 (04): 385-389. |
| [18] | 吴晓艳, 沈清, 孙燕妮. 益气养阴活血化瘀法联合缬沙坦对糖尿病肾病微炎症状态和氧化应激状态的影响 [J]. 现代中西医结合杂志, 2017, 26 (22): 2408-2410+2413. |
| [19] | 郎睿, 余仁欢. 参芪地黄汤治疗慢性肾衰竭有效性机制探讨 [J]. 医学争鸣, 2018, 9 (05): 42-44. |
| [20] | 魏丽娟. 参芪地黄汤在慢性肾脏病中的应用现状及机制浅析 [C]. 中国中西医结合学会肾脏疾病专业委员会. 中国中西医结合学会肾脏疾病专业委员会2018年学术年会论文摘要汇编. 中国中西医结合学会肾脏疾病专业委员会: 中国中西医结合学会, 2018: 1616. |
| [21] | 阮君, 肖铁刚, 陈珺明, 孟胜喜, 宋海燕, 王兵. 人参总皂苷调节非酒精性脂肪肝病大鼠糖脂代谢紊乱机制研究 [J]. 中华中医药学刊: 1-15. |
| [22] | 朱妍, 徐畅. 熟地黄活性成分药理作用研究进展 [J]. 亚太传统医药, 2011, 7 (11): 173-175. |
| [23] | 毛小娟, 王军志, 王凤连. 红芪多糖和黄芪多糖的免疫调节作用 [J]. 中国药理学通报, 1989 (06): 367-372. |
| [24] | 吴慧, 喻嵘, 成细华, 马飞, 魏冠德, 张琴, 程莉娟. 降糖益肾方干预胰岛素信号通路改善转基因2型糖尿病MKR鼠肾损伤的研究 [J]. 湖南中医药大学学报, 2011, 31 (11): 9-11+29. |
| [25] | 董庆海, 吴福林, 王涵, 谭静, 林红强, 刘金平, 周柏松. 山药的化学成分和药理作用及临床应用研究进展 [J]. 特产研究, 2018, 40 (04): 98-103. |
| [26] | 张亚, 周云, 洪志华, 严向明, 张婷, 张建. 山药对大鼠肾缺血再灌注损伤的保护作用 [J]. 江苏医药, 2008 (08): 809-811+752. |
Join the Editorial Board
We invite active, qualified and high profile scientists and researchers to join as Editorial Board Members.
Join UsBecome a Reviewer
Scholars with a strong interest in reviewing are invited to join the reviewer panel to ensure the quality of the research to be published.
Join Us